Question-and-Answer Session
Operator
Thank you, Mr. Fabiano. (Operator Instructions). And your first question comes from the line of Joshua Jabs of Roth Capital. Please proceed.
Joshua Jabs - Roth Capital
Hi, good afternoon.
Anthony Fabiano
Good afternoon, Josh.
Joshua Jabs - Roth Capital
Going back to the inventory, can you give us a little bit of a breakdown both this quarter and last quarter? Once again with the build on in inventory, how much of that is sitting right now with finished products versus materials?
Anthony Fabiano
Josh, give me just a minute I will get that number for you, if you go on to your next question.
Joshua Jabs - Roth Capital
Okay. I know you don't talk specifics about the DoD, potential DoD orders, but can you just give us an update on if there has been any change to what had already been sort of published by the different DoD components towards the end of last year?
Anthony Fabiano
Josh, there has been no change in that. So, it's been the same, it looks the same today as it did at the end of the February-March time frame or even the November time frame, it's just the question of timing.
Joshua Jabs - Roth Capital
So, we should just continue most likely to tract the supplemental. I think they are debating a lot of that here this week and next week.
Anthony Fabiano
That's we are doing.
Ken Galaznik
That's correct.
Joshua Jabs - Roth Capital
Okay. And then, I guess, one of the bigger questions, given what happened with EPS in the quarter. What was the rationale basically for not providing a pre-release heading out of the quarter?
Anthony Fabiano
Josh, we've never, but we did it one time maybe about four years ago and we felt that we stuck to our policy of not saying anything. We didn't like that option.
Joshua Jabs - Roth Capital
Okay. All right.
Anthony Fabiano
Josh, our business too is one that by the difference of a week or two either way, the situation can change dramatically. And with the ability to shift products within days, sometimes of receiving orders, it's not over till it's over. So, the issue of pre-release and then turnaround and having orders come in and shift the product would have been absurd too.
Joshua Jabs - Roth Capital
All right. The last question, ZBV orders, going back, you had a couple of orders that had slipped back; I think that was discussed in the September quarter. Those that slipped, had any of that come through in the quarter? I think there were two separate orders?
- To read the full transcript on Seeking Alpha, click here »
